ALKPositiveIndia
@IndiaAlk
Followers
162
Following
348
Media
7
Statuses
447
India's 1st oncogene focused Patient Support Group: For ALK+ve Lung Cancer Patients, working for better Support, Care & Access to latest Treatment & Research
India
Joined August 2018
Are u/loved one diagnosed with #ALKPositive #LungCancer in #India? Join our 🇮🇳 ALK+ve Lung Cancer #patients & #caregivers community. Email 'alkpositiveindia2017@gmail.com' with WhatsApp, name, city & proof of ALK+ve status to join. You’re not alone💙.@R2SurviveCancer @urvashi01
1
6
8
RT @ALKPositiveinc: At #ALKSummit25 @DanaFarber’s Nancy Campbell says: We hear that “exercise is medicine” & now the CHALLENGE trial confir….
0
7
0
RT @ALKPositiveinc: Dr @sofiamerajver opens day 2 of the #ALKSummit25 discussing all of @UMRogelCancer’s increíble ALK+ cancer research. P….
0
3
0
RT @ALKPositiveinc: ✨ What a weekend!✨. Our 2025 ALK+ Summit wrapped up today — but the connections, knowledge & hope keep going strong. Th….
0
6
0
RT @ALKPositiveinc: #ALKSummit25 KOL panel: What’s the role of local consolidation therapy in ALK+ #lungcancer? . Dr @DRCamidge shares his….
0
12
0
RT @ALKPositiveinc: Meet Colin Barton, awarded our inaugural Spirit of Courage Award for exemplifying our mission, value & community. He’s….
0
3
0
RT @RDakh0811: @IndiaAlk @pfizer @CDSCO_INDIA_INF @PMOIndia Yes sir please make lorlatinib tablet affordable for indians please sir.
0
1
0
RT @RDakh0811: @IndiaAlk @pfizer @CDSCO_INDIA_INF @PMOIndia PMOIndia Respected sir we request you that lorlatinib tablet the cancer drug….
0
1
0
RT @ALKPositiveinc: Dr. Alice Shaw has studied ALK+ #lungcancer since its discovery in 2007. With approx 40K people diagnosed yearly worldw….
0
8
0
RT @ALKPositiveinc: ALK+ #lungcancer community: your experience is powerful. 💪. Join the ALK Life Study—the world’s largest ALK+ cancer re….
0
2
0
RT @JournalCancer: 🚨 Happening now at #ASCO25! The Lung Cancer Rapid Oral Abstract session features key updates on ALK+ #NSCLC 🫁. 📗 From a….
0
5
0
RT @MarioBalsaMD: 🚨 ALNEO (Ph II) at #ASCO25: Neoadj alectinib (8w) → surgery → adj (96w) in stage III ALK+ NSCLC (n=33). Encouraging respo….
0
3
0
RT @urvashi01: Three years ago today, I had absolutely no idea what had just hit me. Stage 4 ALK Positive Lung Cancer at just 35 years of a….
0
16
0
RT @StephenVLiu: Dr. @JessicaJLinMD at #RomeLung25 updates treatment for #ALK NSCLC. Many TKIs approved, PFS greatest for lorlatinib but NV….
0
15
0
RT @AreaQuick: @RWMaloneMD Good! My daughter has a rare cancer NSCLC ALK+. Cancer doesn’t run in our family and she has never smoked. Howev….
0
1
0
RT @Yvonne_Diaz_: Promising signals from the ALEK-B ph 2 trial: combining alectinib w bevacizumab achieved 97.1% 12-mo PFS & median PFS of….
0
11
0
RT @HHorinouchi: ☑️#ASCO25 Abstract🆙.☑️#LCSM Poster.🔥Neladalkib (NVL-655) compared to alectinib in 1L Tx of pts with ALK+ NSCLC: The phase….
0
12
0
0
1
0
RT @ALKPositiveinc: 🎥 Just dropped: ALKtALK Replay!. Hear Dr Ken Culver & team spotlight the impact of our medical committees & the patient….
0
1
0